Actively Recruiting

Age: 2Years - 60Years
All Genders
NCT05332756

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

Led by Beijing Tiantan Hospital · Updated on 2024-12-19

400

Participants Needed

1

Research Sites

243 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The purpose of this study is to investigate the long-term outcomes of conservative management in patients with moyamoya disease and their first-degree relatives, and provide potential pathogenesis of moyamoya disease.

CONDITIONS

Official Title

Long-term Outcomes of Conservative Management in Patients with Moyamoya Disease and Their First-degree Relatives (LAMORA)

Who Can Participate

Age: 2Years - 60Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 2 and 60 years
  • Clinical diagnosis of moyamoya disease, including unilateral or bilateral disease
  • Receiving medical treatment with antiplatelets, antiepileptics, antihypertensives, or vasodilators as needed
  • Able to understand the study purpose and risks and provide informed consent (or have a legal representative provide consent)
  • Able to comply with study follow-up visits
Not Eligible

You will not qualify if you...

  • Presence of other diseases such as systemic vasculitis, neurofibroma, meningitis, sickle cell disease, Down's syndrome, or previous basilar radiotherapy
  • History of cardiogenic embolism including atrial fibrillation, valvular disease, or cardiac valve replacement
  • Allergy to contrast agents
  • Received surgical revascularization treatment
  • Inability or unwillingness to cooperate with examinations or presence of serious comorbid diseases
  • Unlikely or unable to return for follow-up visits
  • Any other conditions that investigators consider make participation unsuitable

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Beijing Tiantan Hospital Capital Medical University

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

Q

Qian Zhang, MD

CONTACT

C

Chaofan Zeng, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here